|
1
|
Heyer BS, Warsowe J, Solter D, Knowles BB
and Ackerman SL: New member of the Snf1/AMPK kinase family, Melk,
is expressed in the mouse egg and preimplantation embryo. Mol
Reprod Dev. 47:148–156. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Joshi K, Banasavadi-Siddegowda Y, Mo X,
Kim SH, Mao P, Kig C, Nardini D, Sobol RW, Chow LM, Kornblum HI, et
al: MELK-dependent FOXM1 phosphorylation is essential for
proliferation of glioma stem cells. Stem Cells. 31:1051–1063. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakano I, Masterman-Smith M, Saigusa K,
Paucar AA, Horvath S, Shoemaker L, Watanabe M, Negro A, Bajpai R,
Howes A, et al: Maternal embryonic leucine zipper kinase is a key
regulator of the proliferation of malignant brain tumors, including
brain tumor stem cells. J Neurosci Res. 86:48–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hebbard LW, Maurer J, Miller A, Lesperance
J, Hassell J, Oshima RG and Terskikh AV: Maternal embryonic leucine
zipper kinase is upregulated and required in mammary
tumor-initiating cells in vivo. Cancer Res. 70:8863–8873. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mirey G, Chartrain I, Froment C, Quaranta
M, Bouché JP, Monsarrat B, Tassan JP and Ducommun B: CDC25B
phosphorylated by pEg3 localizes to the centrosome and the spindle
poles at mitosis. Cell Cycle. 4:806–811. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jung H, Seong HA and Ha H: Murine protein
serine/threonine kinase 38 activates apoptosis signal-regulating
kinase 1 via Thr 838 phosphorylation. J Biol Chem. 283:34541–34553.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seong HA and Ha H: Murine protein
serine-threonine kinase 38 activates p53 function through Ser15
phosphorylation. J Biol Chem. 287:20797–20810. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gu C, Banasavadi-Siddegowda YK, Joshi K,
Nakamura Y, Kurt H, Gupta S and Nakano I: Tumor-specific activation
of the C-JUN/MELK pathway regulates glioma stem cell growth in a
p53-dependent manner. Stem Cells. 31:870–881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin ML, Park JH, Nishidate T, Nakamura Y
and Katagiri T: Involvement of maternal embryonic leucine zipper
kinase (MELK) in mammary carcinogenesis through interaction with
Bcl-G, a pro-apoptotic member of the Bcl-2 family. Breast Cancer
Res. 9:R172007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kuner R, Fälth M, Pressinotti NC, Brase
JC, Puig SB, Metzger J, Gade S, Schäfer G, Bartsch G, Steiner E, et
al: The maternal embryonic leucine zipper kinase (MELK) is
upregulated in high-grade prostate cancer. J Mol Med (Berl).
91:237–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pickard MR, Green AR, Ellis IO, Caldas C,
Hedge VL, Mourtada-Maarabouni M and Williams GT: Dysregulated
expression of Fau and MELK is associated with poor prognosis in
breast cancer. Breast Cancer Res. 11:R602009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gray D, Jubb AM, Hogue D, Dowd P, Kljavin
N, Yi S, Bai W, Frantz G, Zhang Z, Koeppen H, et al: Maternal
embryonic leucine zipper kinase/murine protein serine-threonine
kinase 38 is a promising therapeutic target for multiple cancers.
Cancer Res. 65:9751–9761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moffat J, Grueneberg DA, Yang X, Kim SY,
Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK,
et al: A lentiviral RNAi library for human and mouse genes applied
to an arrayed viral high-content screen. Cell. 124:1283–1298. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chomczynski P and Sacchi N: Single Step
Method of RNA Isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal Biochem.
162:156–159. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi J, Wang DM, Wang CM, Hu Y, Liu AH,
Zhang YL, Sun B and Song JG: Insulin receptor substrate-1
suppresses transforming growth factor-beta1-mediated
epithelial-mesenchymal transition. Cancer Res. 69:7180–7187. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saito RA, Watabe T, Horiguchi K, Kohyama
T, Saitoh M, Nagase T and Miyazono K: Thyroid transcription
factor-1 inhibits transforming growth factor-beta-mediated
epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Cancer Res. 69:2783–2791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Datto MB, Frederick JP, Pan L, Borton AJ,
Zhuang Y and Wang XF: Targeted disruption of Smad3 reveals an
essential role in transforming growth factor beta-mediated signal
transduction. Mol Cell Biol. 19:2495–2504. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Lee YM, Baitsch L, Huang A, Xiang
Y, Tong H, Lako A, Von T, Choi C, Lim E, et al: MELK is an
oncogenic kinase essential for mitotic progression in basal-like
breast cancer cells. Elife. 3:e017632014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alachkar H, Mutonga MB, Metzeler KH,
Fulton N, Malnassy G, Herold T, Spiekermann K, Bohlander SK,
Hiddemann W, Matsuo Y, et al: Preclinical efficacy of maternal
embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid
leukemia. Oncotarget. 5:12371–12382. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chung S and Nakamura Y: MELK inhibitor,
novel molecular targeted therapeutics for human cancer stem cells.
Cell Cycle. 12:1655–1656. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Minata M, Gu C, Joshi K, Nakano-Okuno M,
Hong C, Nguyen CH, Kornblum HI, Molla A and Nakano I: Multi-kinase
inhibitor C1 triggers mitotic catastrophe of glioma stem cells
mainly through MELK kinase inhibition. PLoS One. 9:e925462014.
View Article : Google Scholar : PubMed/NCBI
|
